Tilray also maintained a solid balance sheet, with nearly $250 million in cash and a debt-to-equity ratio of 1.75. Simon highlighted the profitability of Tilray's diversified portfolio, which spans cannabis, hemp food, beverages and pharmaceutical distribution. "Each of those businesses today are profitable," he pointed out.